Sources

5 Total Sources

FDA Approves mRNA Flu Vaccine for Adults 50+ Ahead of 2026 Season

The Seattle Times4h ago

FDA Approves New mRNA Flu Vaccine for Ages 50+ Ahead of Season

8 Vaccine Questions Older Adults Should Ask

FDA approves 1st mRNA flu shot, from Moderna

The vaccine FluMist, manufactured by MedImmune, which was acquired by AstraZeneca in 2007, was first approved by the FDA in 2003 for individuals between five and 49 years of age.

The company behind one of the first COVID mRNA vaccines has now brought the technology to flu. Many traditional flu vaccines are made by growing vaccine viruses in chicken eggs. Scientists have